Episoder
-
Host: Jody Takemoto, PhD
Guest: Bryson Katona, MD, PhD
At the 2024 Digestive Disease Week Annual Meeting, Dr. Bryson Katona presented a session, titled âHigh-Risk Colon Cancer: The ABCs of Genetic Testing.â And now, Dr. Katona is here with Dr. Jody Takemoto to share key insights from his session on genetic testing for patients with high-risk colon cancer. Dr. Katona is the Director of the Gastrointestinal Cancer Genetics Program and Risk Evaluation Program and the Lynch Syndrome Program at Penn Medicine
-
Guest: Andres J. Yarur, MD
Obesity has recently surfaced as an important topic in patients with inflammatory bowel diseases, such as Crohnâs and ulcerative colitis, but historically, these patients have been underweight. This led to the phase III pivotal trials for the use of upadacitinib in patients with moderate to severe ulcerative colitis and Crohnâs disease to see how their baseline BMI would influence the efficacy of the drug. To hear the details and findings of this study, join Dr. Andres Yarur, Associate Professor of Medicine at Cedars Sinai Medical Center in Los Angeles, California. He also presented this study at Digestive Disease Week 2024.
-
Mangler du episoder?
-
Guest: Andres J. Yarur, MD
Health maintenance emphasizes health promotion and disease prevention, which is very important for patients with inflammatory bowel disease (IBD) since theyâre at an increased risk of several life-threatening conditions. Tune in to hear Dr. Andres Yarur discuss essential health maintenance strategies for patients with IBD. Dr. Yarur is an Associate Professor of Medicine at Cedars Sinai Medical Center in Los Angeles, California.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Camilleri, MD
When it comes to irritable bowel syndrome (IBS), itâs important to keep in mind that there are certain diagnoses clinicians can make to specifically treat the underlying problem thatâs causing the symptoms that suggest IBS. To learn more about these complex mimickers, join Dr. Peter Buch as he speaks with Dr. Michael Camilleri, Professor of Medicine at the Mayo Clinic College of Medicine and Science.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David P. Hudesman, MD
Thereâs been an increase in the elderly irritable bowel disease (IBD) population, and itâs estimated that a third of our overall IBD population will soon be over the age of 60. When managing and diagnosing these patients, thereâs different factors to consider, like polypharmacy, biological versus chronological age, how fit these patients are versus how frail they are, and more. To take a deep dive into how IBD is affecting elderly patients, join Dr. Peter Buch as he speaks with Dr. David Hudesman, Professor of Medicine and Co-director of NYU Langoneâs Inflammatory Bowel Disease Center.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Francis Farraye, MD
Patients with inflammatory bowel disease (IBD) have an increased risk of developing infections, and some may be preventable with a vaccine. Approximately 70 percent of patients with ulcerative colitis or Crohnâs disease will be on immunosuppressive therapy at some point during their treatment course, so itâs best to try to address vaccines before theyâre immunosuppressed. So to walk us through some strategies for increasing the number of patients with gastrointestinal diseases who get vaccinated, Dr. Peter Buch is joined by Dr. Farraye, Co-Author of the article, titled âHow to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease,â which appeared in Gastroenterology in 2023 and Professor of Medicine at the Mayo Clinic in Jacksonville, Florida, where he also directs the Inflammatory Bowel Disease Center.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Alexander Ford, MD
Irritable bowel syndrome (IBS) is diagnosed using the ROME 4 criteria, and fortunately, most patients who meet the criteria for IBS clinically are unlikely to have another underlying explanation for their symptoms. However, a common misconception is that IBS is a diagnosis of exclusion, so to learn more about this and other controversies surrounding IBS, join Dr. Peter Buch as he speaks with Dr. Alexander Ford, Professor of Gastroenterology and Honorary Consultant of Gastroenterology at Leeds Institute of Medical Research at St. James University of Leeds.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Wan, MD
Many patients with lower gastrointestinal (GI) bleeding are on anticoagulants, and they may need specific reversal agents depending on what antithrombotic theyâre on. Tune into this episode to learn more about the article that dives into the management and treatment of acute lower GI bleeding and the challenges along the way with Dr. Peter Buch as he speaks with Dr. David Wan, Associate Professor of Medicine at New York-Presbyterian/Weill Cornell Medical Center.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Katherine Falloon, MD
Extraintestinal manifestations (EIMs) that occur in inflammatory bowel disease (IBD) are almost any manifestation that occur outside the gastrointestinal tract. And patients with Crohnâs disease or ulcerative colitis are at an increased risk for developing these manifestations. So to review EIMs in IBD and discuss the importance of a multidisciplinary approach, Dr. Peter Buch is joined by Dr. Katherine Falloon, Gastroenterologist at the Cleveland Clinic.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Ali Soroush, MD, MS
Due to recent technological advancements, the use of artificial intelligence to detect a variety of gastroenterological conditions like Barrettâs esophagus, gastric cancer, and colon polyps is increasingly being explored. Learn about the application, benefits, and pitfalls of artificial intelligence in gastroenterology with Dr. Peter Buch and Dr. Ali Soroush, Assistant Professor of Gastroenterology at Mount Sinai School of Medicine in New York.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Joy Liu, MD
For patients with refractory constipation, itâs important to evaluate the psychological impact of these symptoms. Unfortunately, this disorder can easily affect a patientâs quality of life and keep them from doing their normal routine. So what treatment options can help alleviate some of the burden? Dive in with Dr. Peter Buch as he speaks with Dr. Joy Liu, Instructor of Gastroenterology and Hepatology at the Feinberg School of Medicine at Northwestern.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Prabhleen Chahal, MD
Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis is the most dreaded complication of this procedure. So what are the patient-related, procedure-related, and operator-related risk factors for developing post-ERCP pancreatitis, and how can we work to prevent it? Join Dr. Peter Buch as he speaks with Dr. Prabhleen Chahal, Program Director of the Advanced Endoscopy Fellowship at the Cleveland Clinic.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Benjamin L. Cohen, MD
Guest: Stefan Holubar, MD, MS
Affecting over 25 percent of Crohn's disease patients, perianal disease is a persistent and difficult-to-treat condition. Due to its complex management and significant impact on patients' quality of life, a multidisciplinary approach to care is crucial. Here to discuss the management of perianal Crohnâs disease, Dr. Peter Buch is joined by Dr. Benjamin Cohen, Co-Section Head and Clinical Director for Inflammatory Bowel Disease at Cleveland Clinic, and Dr. Stefan Holubar, IBD Surgery Section Chief and Director of Research at Cleveland Clinic.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Kwo, MD
In patients with chronic live disease, consuming alcohol could contribute to progressive liver damage and a variety of cancers. So alcohol consumption should not be a regular occurrence for those who have underlying chronic liver disease. And approximately four percent of patients with alcohol use disorder are referred at early stages for intervention compared to other liver diseases. To learn more, join Dr. Peter Buch to hear insights from Dr. Paul Kwo, Professor of Medicine and the Director of Hepatology at Stanford University.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Edward L. Barnes, MD, MPH
Pouchitis is a common inflammatory complication after ileal pouch-anal anastomosis (J-pouch) surgery, but the why behind patients who develop this condition seems to be unclear. So to dive into the updated guidelines for the management of pouchitis and to also hear about some knowledge gaps in preventing pouchitis, join Dr. Peter Buch as he takes a deep dive with Dr. Edward Barnes, Associate Professor of Medicine and Associate Fellowship Program Director at the University of North Carolina School of Medicine and Primary Author of article, titled âAGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders,â which was published in Gastroenterology in 2024.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Shilpa Junna, MD
Symptoms of portal vein thrombosis (PVT) are primarily driven by the extent of the obstruction that the PVT is causing, and some of itâs also driven by how quickly the thrombosis has developed. Thereâs also some cases where symptoms can be nonspecific. So the role of a multidisciplinary team in helping to address this condition is very important because every case is unique. This collaboration can help provide the best care to our patients case by case. Dive in with Dr. Peter Buch and Dr. Shilpa Junna, Transplant Hepatologist and Assistant Professor at the Cleveland Clinic, to learn more.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Feuerstadt MD, FACG, AGAF
C. difficile is a major problem in the United States. On top of that, patients who are diagnosed with this infection have the chance of getting caught in a vicious cycle of recurrence. So how can we provide our patients with the best care and work with them to give them the best treatment option? Learn more with Dr. Peter Buch as he takes a deep dive with Dr. Paul Feuerstadt, Assistant Clinical Professor of Medicine at Yale-New Haven Hospital.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Lucey, MD
There are a lot of considerations to keep in mind when it comes to liver transplantation in patients with various diseases, like metabolic-associated stereotactic liver diseases, alcoholic liver disease, hepatitis B and C, and more. Joining Dr. Peter Buch to discuss those key considerations surrounding liver transplantation is Dr. Michael Lucey, Professor of Medicine at the University of Wisconsin School of Medicine and Public Health.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Talan, MD
Until recently, surgery was always utilized for appendicitis, but now, antibiotics are an alternative treatment. Find out who the best candidates are for an antibiotic regimen, the efficacy and safety of this approach to treating acute uncomplicated appendicitis, and more with Dr. Peter Buch and Dr. David Talan, Professor of Medicine at UCLA Geffen School of Medicine.
-
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Benjamin Schmidt, MD
Itâs become clear that social media is here to stay, and itâs become a way that people get their information and spread information. Dive into this episode to learn about the benefits and challenges of social media in healthcare from a recently published article with Dr. Peter Buch and Dr. Benjamin Schmidt, Gastroenterologist at Esse Health in St. Louis, Missouri. Heâs also the author of the article, titled âHow a GI Fellow Found a Following: Harnessing the Power of Social Media for Education and Fun,â which was published in Digestive Diseases and Sciences in 2023.
- Se mer
